Dow Up2.00% Nasdaq Up1.66%

Corcept Therapeutics Incorporated (CORT)

-NasdaqCM
3.86 Up 0.11(2.93%) Feb 12, 4:00PM EST
|After Hours : 3.86 Up 0.00 (0.02%) Feb 12, 5:07PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 13,261   11,956   10,102   9,014  
Cost of Revenue256  439  302  258  
Gross Profit 13,005   11,517   9,800   8,756  
Operating Expenses
Research Development3,612  3,341  4,377  3,789  
Selling General and Administrative9,291  9,342  9,453  8,044  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 102   (1,166) (4,030) (3,077)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes102  (1,166)(4,030)(3,077)
Interest Expense703  770  800  818  
Income Before Tax(601)(1,936)(4,830)(3,895)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(601)(1,936)(4,830)(3,895)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (601) (1,936) (4,830) (3,895)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (601) (1,936) (4,830) (3,895)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.